(Q45115322)

9 December 2017

IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity (English)

1 reference

9 December 2017

1 reference

1

1 reference

9 December 2017

4

1 reference

9 December 2017

6

1 reference

9 December 2017

Koek GH

2

1 reference

9 December 2017

Robaeys G

series ordinal

3

1 reference

9 December 2017

Scharpé S

series ordinal

5

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

9 December 2017

1 reference

9 December 2017

10

1 reference

9 December 2017

6

1 reference

9 December 2017

538-544

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001600

9 December 2017

0 references

cites work

A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Paroxetine for the prevention of depression induced by high-dose interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Role of 5-HT in stress, anxiety, and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Association of a Critical CSF Tryptophan Threshold Level with Depressive Relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Predictors of mood response to acute tryptophan depletion. A reanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Evidence for an immune response in major depression: a review and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Indicators of immune activation in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

The relationship of depression and stressors to immunological assays: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Tryptophan as a link between psychopathology and somatic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Endogenous neurotoxins from tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Quinolinic acid induces oxidative stress in rat brain synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

The pharmacological manipulation of glutamate receptors and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Epigallocatechin 3-gallate attenuates neuronal damage induced by 3-hydroxykynurenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Blood?Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Human microglia convert l-tryptophan into the neurotoxin quinolinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Brain quinolinic acid in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Increased brain 3-hydroxykynurenine in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Hippocampal volume reduction in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

A magnetic resonance imaging study of putamen nuclei in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Glial reduction in the subgenual prefrontal cortex in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Endogenous kynurenines as targets for drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Untreated Depression and Hippocampal Volume Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Tryptophan transport through the blood-brain barrier: In vivo measurement of free and albumin-bound amino acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

Tryptophan metabolism through the kynurenine pathway in rat brain and liver slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

inferred from DOI database lookup

7 January 2021

based on heuristic

3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

inferred from DOI database lookup

7 January 2021

based on heuristic

Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001600

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.MP.4001600

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference